142 related articles for article (PubMed ID: 4148581)
1. Dexetimide: an effective drug for the control of extrapyramidal symptoms induced by pipothiazine palmitate.
Dom R; Van Lommel R; Baro F
Acta Psychiatr Scand; 1973; 49(5):563-9. PubMed ID: 4148581
[No Abstract] [Full Text] [Related]
2. A quantitative study of neuroleptic-induced extrapyramidal symptoms and their response to dexetimide, a potent and long-acting antiparkinsonian agent.
Dom R; Van Lommel R; Baro F
Acta Psychiatr Scand; 1971; 47(4):399-410. PubMed ID: 4947805
[No Abstract] [Full Text] [Related]
3. A long-term pilot study of pipothiazine palmitate in chronic schizophrenia.
Villeneuve A; Pires A; Jus A; Lachance R; Drolet A
Curr Ther Res Clin Exp; 1972 Nov; 14(11):696-706. PubMed ID: 4404626
[No Abstract] [Full Text] [Related]
4. Clinical experience with pipothiazine palmitate (19552 R.P.) in hospitalized and open ward patients with functional psychoses.
Salvesen C; Vaksdal K
Behav Neuropsychiatry; 1973 Oct-1974 Mar; 5(7-12):3-7. PubMed ID: 4154740
[No Abstract] [Full Text] [Related]
5. Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action.
Huygens H; Vereecken JL; Tanghe A
Psychiatr Neurol Neurochir; 1973; 76(4):251-9. PubMed ID: 4581374
[No Abstract] [Full Text] [Related]
6. A controlled one-year study of pipotiazine palmitate and fluphenazine decanoate in chronic schizophrenic syndromes. Evaluation of results at 6 and 12 months' trial.
Dencker SJ; Frankenberg K; Malm U; Zell B
Acta Psychiatr Scand Suppl; 1973; 241():101-18. PubMed ID: 4147508
[No Abstract] [Full Text] [Related]
7. General evaluation of pipotiazine palmitate (19.552 R.P.) in hospitalized schizophrenic patients.
Gerlach J; Nyeborg O; Prieto R
Acta Psychiatr Scand Suppl; 1973; 241():69-74. PubMed ID: 4147513
[No Abstract] [Full Text] [Related]
8. Clinical experience with pipotiazine palmitate (19.552 R.P.) in Nordic countries. Report of a multicentre investigation.
Kristjansen P; Dencker SJ; Elley J; Hakola A; Heshe J; Malm U; Robak OH; Salvesen C; Vaksdal K
Acta Psychiatr Scand Suppl; 1973; 241():51-6. PubMed ID: 4147511
[No Abstract] [Full Text] [Related]
9. Pipotiazine palmitate (19.552 R.P.) in the long-term treatment of chronic psychoses. A controlled trial on in-patients.
Robak OH
Acta Psychiatr Scand Suppl; 1973; 241():83-94. PubMed ID: 4147515
[No Abstract] [Full Text] [Related]
10. Monthly intermittent chemotherapy of chronic schizophrenic outpatients with pipothiazine palmitate.
Laurent JS; Carle R; Dumais B; Domingue D
Can Psychiatr Assoc J; 1974 Dec; 19(6):583-91. PubMed ID: 4155349
[No Abstract] [Full Text] [Related]
11. Biperiden (Akineton): effective prophylactic and therapeutic anti-parkinsonian agent.
Kline NS; Mason BT; Winick L
Curr Ther Res Clin Exp; 1974 Aug; 16(8):838-43. PubMed ID: 4155670
[No Abstract] [Full Text] [Related]
12. Basic principles in the use of antipsychotic agents.
Mason AS
Hosp Community Psychiatry; 1973 Dec; 24(12):825-9. PubMed ID: 4148176
[No Abstract] [Full Text] [Related]
13. [The effect of dexbenzetimide (Tremblex - Gedeon Richter) on postneuroleptic extrapyramidal syndromes (author's transl)].
Firko M; Morasiewicz J; Puchała G
Psychiatr Pol; 1981; 15(2):139-44. PubMed ID: 6118905
[No Abstract] [Full Text] [Related]
14. Uncontrolled study with pipothiazine palmitate.
Jain RC; Ananth JV; Klingner A; Ban TA; Lehmann HE
Int J Clin Pharmacol; 1973 Feb; 7(1):32-6. PubMed ID: 4699381
[No Abstract] [Full Text] [Related]
15. Drug induced extrapyramidal effects--a review.
Coleman JH; Hayes PE
Dis Nerv Syst; 1975 Oct; 36(10):591-3. PubMed ID: 1100334
[No Abstract] [Full Text] [Related]
16. Review of clinical trials with pipotiazine, pipotiazine undecylenate and pipotiazine palmitate.
Brown-Thomsen J
Acta Psychiatr Scand Suppl; 1973; 241():119-38. PubMed ID: 4151807
[No Abstract] [Full Text] [Related]
17. Clinical evaluation of pipotiazine palmitate (19.552 R.P.) used on patients in an acute reception ward.
Elley JH; Petersen JH
Acta Psychiatr Scand Suppl; 1973; 241():75-82. PubMed ID: 4147514
[No Abstract] [Full Text] [Related]
18. Extrapyramidal reactions in adolescents treated with high-potency antipsychotics.
Chiles JA
Am J Psychiatry; 1978 Feb; 135(2):239-40. PubMed ID: 23686
[No Abstract] [Full Text] [Related]
19. Assessment of drugs in schizophrenia. Discussion on assessment of drug-induced extrapyramidal reactions.
McClelland HA
Br J Clin Pharmacol; 1976 Jun; 3(3 Suppl 2):401-3. PubMed ID: 9966
[No Abstract] [Full Text] [Related]
20. [Amantadine and dexetimide in the treatment of parkinsonism].
Hakkarainen H; Viukari M
Duodecim; 1973 Jul; 89(21):1437-41. PubMed ID: 4586970
[No Abstract] [Full Text] [Related]
[Next] [New Search]
